Page 3 of 7
Which participants were included in this study?
Studies have a list of requirements for participants who can enrol (inclusion criteria)
and those who can’t (exclusion criteria). For this study, the main inclusion and
exclusion criteria are listed below.
Men and women were included in the study if they:
• Were at least 18 years old.
• Received daily CAB and RPV tablets for six years as part of
Study LAI116482.
• Had an undetectable viral load at least 12 weeks before Day 1.
Men and women were excluded from the study if they had:
• A viral load of 50 c/mL or more at least twice within six months before
Day 1.
• A viral load of 200 c/mL or more at least once within six months before
Day 1.
• Any other disease(s), abnormal blood test results, or taken any
medicine(s) that the study doctor thought would affect the results of the
study.
Overall, 97 participants received at least one dose of the study medicines. The study
included 95 participants (98%) who were assigned male at birth and 2 participants (2%)
who were assigned female at birth. Of these, 94 participants identified as male and
3 participants identified as female. The average age was 42 years. The youngest
participant was 25 years old and the oldest participant was 63 years old.
For more detailed information about the participants included in this study, see the
scientific results summary (a link to the summary is provided at the end of this
document).